Global and Japan Anti-inflammatory Therapeutics Market Size, Status and Forecast 2021-2027

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Market Analysis and Insights: Global Anti-inflammatory Therapeutics Market
The global Anti-inflammatory Therapeutics market size is projected to reach US$ 157690 million by 2027, from US$ 104120 million in 2020, at a CAGR of 6.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-inflammatory Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-inflammatory Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-inflammatory Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-inflammatory Therapeutics market.

Global Anti-inflammatory Therapeutics Scope and Market Size
Anti-inflammatory Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

On the basis of product

type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA